Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225718 · ClinicalTrials.gov registry record
Ceftriaxone in Non-neutropenic Fever
A clinical trial of Histiocytosis and Pediatric Patients With Cancer, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 463
- Enrollment target
- 1
- Study location
NCT01225718: Completed study of Histiocytosis and Pediatric Patients With Cancer, sponsored by Vanderbilt University Medical Center.
NCT01225718 is a study of Histiocytosis and Pediatric Patients With Cancer that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 463 participants, below the 1,325-participant average among 5 other Histiocytosis trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01225718, a study of Histiocytosis and Pediatric Patients With Cancer, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 463 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective chart review of all patients cared for at Monroe Carell Jr. Children's Hospital at Vanderbilt including the following: * patients between 2007-2009 with malignancy, Langerhans cell histiocytosis (LCH) or hemophagocytic lymphohistiocytosis (HLH) and a central venous catheter who were under 23 years of age at time of diagnosis in order to ascertain the associated symptoms, management and outcome of all episodes of non-neutropenic fever. * to identify a subset of low-risk patients that can be safely managed without use of empiric antibiotics.
Conditions Studied
Study Locations (1)
Tennessee
- Monroe Carrell Jr. Children's Hospital at Vanderbilt - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2010-08 |
| Est. Completion | 2016-06-25 |
What the finished NCT01225718 record still lists
NCT01225718 is an observational study that tracks outcomes without assigning an intervention. The registered 463 participants enrollment target is mid-sized for trials with a published cap, below the 1,325-participant average among 5 other Histiocytosis trials with a reported enrollment target (65% lower).
The record links to 2 conditions, with Histiocytosis appearing as the primary indexed condition, and to 0 interventions.
NCT01225718 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01225718 about?
NCT01225718 is a clinical study titled "Ceftriaxone in Non-neutropenic Fever". This is a retrospective chart review of all patients cared for at Monroe Carell Jr. Children's Hospital at Vanderbilt including the following: * patients between 2007-2009 with malignancy, Langerhans cell histiocytosis (LCH) or hemophagocytic lymphohistiocytosis (HLH) and a central venous catheter ...
What is the current status of trial NCT01225718?
This trial is currently completed. The enrollment target is 463 participants. The study started on 2010-08. Estimated completion is 2016-06-25.
What conditions does trial NCT01225718 study?
This clinical trial studies the following conditions: Histiocytosis, Pediatric Patients With Cancer.
Who is sponsoring clinical trial NCT01225718?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01225718 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Histiocytosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Histiocytic Disorder Follow-up Study
RECRUITING
-
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RECRUITING · Phase 1
-
A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis
ACTIVE NOT RECRUITING
-
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
COMPLETED · Phase 2
-
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT06444295 · 464 participants · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia